Cancer malignancy is enhanced by glyceraldehyde-derived advanced glycation end-products
about
Serum Levels of Toxic AGEs (TAGE) May Be a Promising Novel Biomarker for the Onset/Progression of Lifestyle-Related DiseasesCurrent perspectives on the health risks associated with the consumption of advanced glycation end products: recommendations for dietary managementContribution of the toxic advanced glycation end-products-receptor axis in nonalcoholic steatohepatitis-related hepatocellular carcinomaObesity and cancer: at the crossroads of cellular metabolism and proliferationGlycation of extracellular matrix proteins impairs migration of immune cells.Advanced glycation end products influence oral cancer cell survival via Bcl-xl and Nrf-2 regulation in vitroToxic AGE (TAGE) Theory for the Pathophysiology of the Onset/Progression of NAFLD and ALDCell migration is regulated by AGE-RAGE interaction in human oral cancer cells in vitro.Identification of core T cell network based on immunome interactome.Structural changes in histone H2A by methylglyoxal generate highly immunogenic amorphous aggregates with implications in auto-immune response in cancer.Advanced glycation endproducts (AGEs) in saliva of patients with multiple myeloma - a pilot study.Glycative stress from advanced glycation end products (AGEs) and dicarbonyls: An emerging biological factor in cancer onset and progression.Advanced Glycation End-Products Enhance Lung Cancer Cell Invasion and Migration.Glyceraldehyde-Derived Advanced Glycation End Products Accumulate Faster Than Nε-(Carboxymethyl) Lysine.Glucose-derived AGEs enhance human gastric cancer metastasis through RAGE/ERK/Sp1/MMP2 cascade.Ousting RAGE in melanoma: A viable therapeutic target?A novel monoclonal antibody targeting carboxymethyllysine, an advanced glycation end product in atherosclerosis and pancreatic cancer.DNA-aptamers raised against AGEs as a blocker of various aging-related disorders.
P2860
Q26747425-593C90BA-8F82-4AA2-BD8F-1F9F1019AF50Q26781156-49246CDA-A042-4B0B-BC0B-14DEAD6979D2Q26781477-56AAAD37-8507-4852-92FE-52834327F834Q27003989-55FC9C98-2BA2-465A-8306-C55FEA1D7929Q30317492-5F826A9C-1934-4737-8FBB-EA274682272CQ33686550-A4C4BAB4-21BE-4B17-82AC-27FC147F1A3EQ33852213-9F7E211F-A756-4D90-8EB5-284BD83F6391Q34352301-0EFEB474-C57F-4B89-B4DC-CC08C152A759Q35094597-ACC170FE-9AE9-474A-B544-D0977FB82578Q35789219-3F108243-313D-458B-AE26-2C02C10C79F0Q38692562-E024949D-B80B-4A46-A391-FBB3ADD6498FQ38698770-3E6BFF7F-1587-452B-9731-2CDB25035AEAQ38752287-2F0E98DB-D0E2-4E47-8B30-9E7DA64ED30BQ40955558-6C00B865-99CC-494E-937B-34B32EFAE3C8Q47162610-CEF3476F-ADB0-4E7A-BDBA-D757FCF7C176Q47593410-7A426535-33BB-4C05-8150-DBAD426C071DQ50114572-EA2AA0B4-7172-492E-8751-42D6CD88505BQ51685125-90986B12-860E-4C73-9739-8B9A5BFB7D79
P2860
Cancer malignancy is enhanced by glyceraldehyde-derived advanced glycation end-products
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Cancer malignancy is enhanced by glyceraldehyde-derived advanced glycation end-products
@en
Cancer malignancy is enhanced by glyceraldehyde-derived advanced glycation end-products
@nl
type
label
Cancer malignancy is enhanced by glyceraldehyde-derived advanced glycation end-products
@en
Cancer malignancy is enhanced by glyceraldehyde-derived advanced glycation end-products
@nl
prefLabel
Cancer malignancy is enhanced by glyceraldehyde-derived advanced glycation end-products
@en
Cancer malignancy is enhanced by glyceraldehyde-derived advanced glycation end-products
@nl
P2093
P2860
P356
P1433
P1476
Cancer malignancy is enhanced by glyceraldehyde-derived advanced glycation end-products
@en
P2093
Jun-Ichi Takino
Masayoshi Takeuchi
Sho-Ichi Yamagishi
P2860
P304
P356
10.1155/2010/739852
P577
2010-06-29T00:00:00Z